73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study to determine which stool test is best for colorectal cancer detection

Study to determine which stool test is best for colorectal cancer detection

by Texas Tech UniversityNavkiran Shokar, M.D., M.P.H., M.A., of Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) is part of a study to assess the accuracy of fecal immunochem

Study to determine which stool test is best for colorectal cancer detection

by Texas Tech UniversityNavkiran Shokar, M.D., M.P.H., M.A., of Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) is part of a study to assess the accuracy of fecal immunochem
A compound effective against chemotherapy-resistant cancer cells identified

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou
Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys
Health insurance premiums dropped? Not so fast

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he
Few with CRC in sub-Saharan Africa receive guideline-concordant care

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September
Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l
New microfluidic device shows tumor shape predicts cancer aggressiveness

New microfluidic device shows tumor shape predicts cancer aggressiveness

byUniversity of TorontoThe image shows culture, release and transfer of the tumoroids from the ReSCUE platform, as well as the released breast cancer disk-, rod-, and U-shaped tumoroids cultured

New microfluidic device shows tumor shape predicts cancer aggressiveness

byUniversity of TorontoThe image shows culture, release and transfer of the tumoroids from the ReSCUE platform, as well as the released breast cancer disk-, rod-, and U-shaped tumoroids cultured
Researchers relate amplification of chromosomal region with resistance to chemotherapeutic drug in breast cancer

Researchers relate amplification of chromosomal region with resistance to chemotherapeutic drug in breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteEmergence of docetaxel resistance. Credit: Eva González-SuárezResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), with the part

Researchers relate amplification of chromosomal region with resistance to chemotherapeutic drug in breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteEmergence of docetaxel resistance. Credit: Eva González-SuárezResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), with the part
Potential therapeutic target for small cell lung cancer discovered

Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce

Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce
Researchers discuss HER2-low and HER2-zero in breast cancer

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot
Researchers develop scalable synthesis of cancer-fighting compounds

Researchers develop scalable synthesis of cancer-fighting compounds

byH. Lee Moffitt Cancer Center & Research InstituteCredit:Science Advances(2024). DOI: 10.1126/sciadv.adp9375Withanolides, a class of naturally occurring compounds found in plant

Researchers develop scalable synthesis of cancer-fighting compounds

byH. Lee Moffitt Cancer Center & Research InstituteCredit:Science Advances(2024). DOI: 10.1126/sciadv.adp9375Withanolides, a class of naturally occurring compounds found in plant
New model could reduce reliance on chemotherapy

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast